The Surgeon Who Promised Miracles: Paolo Macchiarini and the Synthetic Trachea That Killed His Patients

For a few years in the early 2010s, Paolo Macchiarini was one of the most celebrated surgeons in the world. He had apparently done the impossible: grown a patient’s own stem cells on a plastic scaffold and implanted it as a functioning windpipe. The scientific press called it a revolution in regenerative medicine. The Karolinska Institutet in Stockholm, the institution that awards the Nobel Prize in Physiology or Medicine, recruited him as a visiting professor. When he walked into operating rooms, he was greeted with the reverence usually reserved for figures who have genuinely changed medicine forever.

Seven of the eight patients who received one of his synthetic trachea transplants are dead. The eighth is severely disabled. Macchiarini fabricated significant portions of his academic credentials. He published research papers describing patient outcomes that bore no resemblance to what actually happened to his patients. He told patients and their families that the procedures had been tested in animals, a claim that could not be verified. He told one patient’s family their loved one was doing well when their loved one was in crisis. He performed at least one operation on a patient who likely had another viable treatment available. And while all of this was unravelling, he was maintaining a romantic relationship with an NBC News television producer to whom he had fabricated an entire parallel biography, including claims that he regularly operated on the Pope and was to be married at the Vatican with world leaders as his witnesses.

His story is medicine’s most complete modern cautionary tale about how institutional prestige, scientific ambition, and the human appetite for miracle cures can combine to create conditions in which extraordinary harm goes undetected for years.

Background: The Promise of Regenerative Surgery

Paolo Macchiarini was born in Italy on August 22, 1958, and trained as a thoracic surgeon. By 2010, when the Karolinska Institutet appointed him as a visiting professor, he had an impressive publication record and a reputation as a bold innovator in airway surgery. The year before, he had performed what was described as the world’s first tissue-engineered trachea transplant in Barcelona, using a donor trachea from a cadaver that had been seeded with the patient’s own stem cells. The procedure was published in The Lancet and attracted enormous attention.

His 2011 move to Karolinska brought him to an institution of unparalleled symbolic importance in medicine. He began performing a further development of the technique there: instead of a cadaver trachea, he would use a synthetic plastic scaffold, seeded with stem cells taken from the patient’s own bone marrow. The theory was that the stem cells would grow into the scaffold, integrating with the patient’s tissue, and the plastic would eventually be replaced by living trachea. If it worked, it would transform the treatment of tracheal cancer and injury. It did not work.

The Patients at Karolinska

Three patients received synthetic trachea transplants at Karolinska University Hospital in 2011 and 2012. Their names were Andemariam Teklesenbet Beyene, Christopher Lyles, and Yesim Cetir.

Andemariam Teklesenbet Beyene was an Eritrean graduate student studying in Iceland who had a slow-growing cancer obstructing his windpipe. The cancer was serious, but experts who later reviewed his case concluded that his cancer’s slow progression meant other treatment options likely could have sustained him for a meaningful period. He received the synthetic trachea transplant in 2011. His tracheal implant began to fail almost immediately. By the time he died, the implant had almost completely disconnected from his airway. He was 36 years old.

Christopher Lyles was a 30-year-old American with tracheal cancer. He died in January 2014, approximately two years after his surgery, from complications related to the failed implant.

Yesim Cetir was a teenager from Turkey whose trachea had been accidentally damaged during a previous surgical procedure. Unlike the other two patients, her underlying condition was not a life-threatening cancer. Expert witnesses at Macchiarini’s trial would later testify that she had viable alternatives to the experimental surgery. She died in 2017.

In each case, the published descriptions of the patients’ post-operative conditions that appeared under Macchiarini’s name in scientific journals did not accurately reflect what was happening to the patients. The papers described outcomes that were not occurring. They described functioning tracheas in patients whose implants were failing.

Macchiarini also performed trachea transplant operations in Russia and in the United States, where a two-year-old girl named Hannah Warren, who had been born without a windpipe, received a synthetic trachea at a hospital in Illinois. Hannah Warren died less than three months after surgery. She was the youngest of his patients.

The Whistleblowers Inside the Institution

Four of Macchiarini’s colleagues at Karolinska, Karl-Henrik Grinnemo, Matthias Corbascio, Thomas Fux, and Oscar Simonson, began raising concerns about his work as early as 2013. They reviewed his papers and compared what was described in the published literature with what they observed in the patients. The two did not match. They filed formal misconduct complaints with the Karolinska Institutet.

The institution’s initial response was to investigate and clear Macchiarini. The vice chancellor, Anders Hamsten, determined in 2015 that there was no basis for the misconduct findings. Macchiarini retained his position and continued his work. The four doctors who had raised concerns found their professional situations within the institution deteriorating. “We were not against Karolinska and the hospital,” Grinnemo later said. “But the way they handled the situation was a form of misconduct. They didn’t listen to our warnings.”

The case broke open publicly in January 2016 when the Swedish public broadcaster SVT aired a three-part documentary series called “The Experiment.” The documentary, made by journalist Bosse Lindquist over several years, showed the gap between what Macchiarini had published and what had happened to his patients. The public response in Sweden was enormous. Within days, Karolinska’s chairman was calling for an independent investigation. The institution’s secretary of the Nobel Committee for Physiology or Medicine, Urban Lendahl, resigned over his role in recruiting Macchiarini. Vice Chancellor Hamsten, who had cleared Macchiarini six months earlier, resigned shortly afterward.

The Fabricated Life

Concurrent with the unravelling of his scientific reputation was the exposure of a personal fraud of equal scope. Benita Alexander was an NBC News television producer who met Macchiarini in 2013 while working on a documentary about a trachea transplant he performed on a two-year-old girl. They became romantically involved. Macchiarini told her that he regularly performed surgery on Pope Francis, that he socialised with Barack Obama and Vladimir Putin, that he had been asked by the United Nations Secretary-General to set up a medical facility in Kazakhstan, and that they would be married at a private ceremony in Rome hosted by Pope Francis himself, with Obama, the Clintons, and other heads of state in attendance.

None of it was true. The wedding was cancelled. Alexander’s account of the relationship, which she later made public, documented a con of extraordinary ambition: a man who had constructed a version of himself so elevated, so connected, and so important that the institutions around him found it easier to believe him than to check. His academic credentials, too, were found to contain significant falsehoods. Karolinska reviewed his CV and identified multiple discrepancies.

The Criminal Proceedings and the Medical Ethics Question

The criminal prosecution of Paolo Macchiarini was slow and complicated. In 2017, Swedish prosecutors charged him with manslaughter in connection with the deaths of the three Karolinska patients. They dropped those charges within months, saying they lacked sufficient evidence to meet the manslaughter standard. In 2019, an Italian court convicted him of forging documents and abuse of office, sentencing him to 16 months.

Swedish prosecutors reopened their investigation in 2020 and charged him on lesser counts: aggravated assault and severe bodily harm in relation to the three Karolinska patients. The trial took place in Sweden in spring 2022. The district court in Solna found Macchiarini not guilty of the most serious charges in relation to Beyene and Lyles, on the grounds that their prognoses without surgery had been so poor that the court could not find Macchiarini criminally indifferent to the risk. In the case of Yesim Cetir, whose underlying condition was not immediately life-threatening and who had other options, the court found him guilty of one count of causing bodily harm, a felony. He received a suspended sentence.

An appeal produced a more significant result. In June 2023, a Swedish appeals court sentenced Macchiarini to two and a half years in prison, finding that all three deceased patients “could have lived for a not-insignificant amount of time without the interventions.” He appealed to Sweden’s Supreme Court. The court declined to hear the case. He is expected to serve his sentence in Spain, where he currently lives.

The legal proceedings illuminated a fundamental question in the ethics of experimental medicine: when does a researcher’s decision to proceed with an unproven, potentially lethal procedure cross the line from acceptable risk-taking into criminal negligence or worse? Expert witnesses at the trial were clear that the synthetic tracheas Macchiarini implanted had no established scientific basis for success in humans. As the expert Pierre Delaere put it: “When you implant a synthetic trachea you have one certainty, and that is that the patient will die as a result of it.” Macchiarini had framed his operations as compassionate care for patients with no other options. In at least one case, that framing was demonstrably false.

The Institutional Failure at Karolinska

The Macchiarini case is not only a story about one surgeon. It is a story about how institutions built around prestige can lose the ability to apply the same critical scrutiny to their own members that they apply to outside claims. Karolinska Institutet is one of the most prestigious medical research universities in the world. Its connection to the Nobel Prize confers an authority that ordinarily functions as a quality signal. In the Macchiarini case, that prestige appears to have worked in the opposite direction, creating a protective circle around a man whose work was killing his patients because his failure was too embarrassing to acknowledge.

The four doctors who raised concerns were not outsiders. They were colleagues at the same institution. Their concerns were formally documented and formally dismissed. The Swedish documentary that finally forced accountability was made by a journalist, not by any medical or scientific body. The Nobel Committee’s secretary resigned over his role in recruiting Macchiarini. The vice chancellor resigned. Multiple papers were retracted. The reputational damage to the institution was enormous and lasting.

The Macchiarini case has since been studied by bioethicists as an example of how the mechanisms that are supposed to police experimental medicine, from institutional review boards to peer review to whistleblower protection systems, can all fail simultaneously when sufficient prestige and charisma are in play.

TL;DR: Key Facts, Legal Concepts, and Why This Case Matters

Who was Paolo Macchiarini?

Paolo Macchiarini (born August 22, 1958, Italy) was a thoracic surgeon and regenerative medicine researcher who was a visiting professor at the Karolinska Institutet in Stockholm from 2010 to 2016. He performed experimental synthetic trachea transplants on patients in Sweden, Russia, and the United States. Seven of the eight patients who received his synthetic tracheas died. He was convicted of criminal harm by a Swedish court and sentenced to two and a half years in prison in 2023.

What were the synthetic trachea transplants?

Macchiarini’s technique involved seeding a plastic scaffold with stem cells taken from the patient’s own bone marrow, then implanting the construct as a replacement windpipe. The theory was that the stem cells would grow into the scaffold and replace it with living tissue. This did not happen. Patients’ bodies rejected or failed to integrate the implants, leading to infections, structural failure, and death. Macchiarini claimed the technique had been tested in animals before being used in humans; this claim could not be verified and may have been false.

How were the fraudulent published results discovered?

Four of Macchiarini’s colleagues at Karolinska filed formal research misconduct complaints after comparing his published descriptions of patients’ post-operative conditions with what they observed clinically. The papers described patients improving when they were in fact failing. The institution initially cleared Macchiarini in 2015. Public accountability only came after a Swedish public broadcaster aired a three-part documentary in January 2016, at which point the institution’s leadership resigned and independent investigations were launched.

What is the boundary between experimental surgery and criminal negligence?

Experimental surgery is permissible when there is a reasonable scientific basis for believing it may benefit the patient, when the patient has been fully informed of the experimental nature of the procedure, when genuine alternatives have been considered and disclosed, and when the procedure has appropriate regulatory and ethical approval. Macchiarini’s conduct violated each of these requirements in different ways at different times. In the case of Yesim Cetir, for whom alternatives existed, the Swedish court found that proceeding with the experimental surgery when the expected risk outweighed any expected benefit constituted a criminal act.

What happened to the Karolinska Institutet?

The scandal caused severe reputational and institutional damage to Karolinska Institutet. The secretary of the Nobel Committee for Physiology or Medicine, Urban Lendahl, resigned for his role in recruiting Macchiarini. Vice Chancellor Anders Hamsten, who had cleared Macchiarini of misconduct in 2015, also resigned. Multiple papers co-authored by Macchiarini were retracted. The institution commissioned an independent external inquiry into how the case had been handled from Macchiarini’s recruitment in 2010 through the period of the complaints.

What sentence did Macchiarini ultimately receive?

A Swedish district court convicted Macchiarini of one count of causing bodily harm in 2022 and gave him a suspended sentence. The Swedish appeals court, reviewing the case in 2023, sentenced him to two and a half years in prison and found that all three deceased Karolinska patients could have survived longer without his interventions. Sweden’s Supreme Court declined to hear his further appeal. He is expected to serve the sentence in Spain. An Italian court had separately sentenced him to 16 months in 2019 for document forgery and abuse of office.

What does this case mean for research ethics?

The Macchiarini case has become a reference point in bioethics for the failure of multiple simultaneous oversight mechanisms: institutional review, peer review, whistleblower response systems, and national regulatory oversight all failed to stop procedures that were killing patients. It also raised pointed questions about the role of institutional prestige in inhibiting critical scrutiny, and about the specific vulnerabilities of patients who are told they have no other treatment options and therefore accept risk that would otherwise be unacceptable.